Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

OSI-774 to be tested in combination therapy for NSCLC

July 26, 2001

Enzon begins phase II trial of Prothecan

July 26, 2001

New antitumor compounds in development at Pharmacia

July 25, 2001

Survival prolonged in tumor-bearing mice treated with GTI-2040

July 25, 2001

ProChon and MorphoSys identify new class of antibody

July 25, 2001

Methotrexate-albumin conjugate may be particularly useful against prostate cancer, sarcomas

July 25, 2001

QLT and Novartis Ophthalmics expand verteporfin codevelopment agreement

July 25, 2001

FDA advisory committee to review IntraDose

July 25, 2001

Cell Matrix awarded grants for development of novel antiangiogenesis products

July 25, 2001

Patient enrollment completed in SafeScience phase II pancreatic cancer trial

July 24, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...